Pharma VC Funds

Broadview Ventures, founded in 2008 and headquartered in Boston, Massachusetts, is a venture capital firm focused on investing in early-stage life sciences companies. The firm specializes in cardiovascular and neurovascular diseases, aiming to bridge the translational gap between scientific research and clinical application. Broadview Ventures has a robust portfolio that includes companies such as DecImmune Therapeutics, which develops therapies to mitigate injury post-myocardial infarction, and FineHeart, a French medical device company creating innovative cardiac support technologies. Other notable investments include GI Windows, developing non-surgical approaches for treating chronic diseases, and Adient Medical, focusing on absorbable medical devices. The firm has made 79 investments and achieved several successful exits, including Cardialen, VentriNova, and Renovacor. Broadview's investment strategy leverages their extensive industry expertise and network to support companies from seed through later stages of development. Broadview Ventures is led by a team of experienced professionals dedicated to advancing healthcare through innovative solutions. Their strategic focus and targeted investments aim to address unmet medical needs, ultimately improving patient outcomes and advancing the field of cardiovascular and neurovascular health.

Brooklyn Bridge Ventures (BBV), founded in 2012 by Charlie O'Donnell, is a pioneering early-stage venture capital fund based in Brooklyn, New York. BBV primarily focuses on leading or co-leading pre-seed and seed rounds, targeting startups in the New York City area that have raised less than $750,000 in prior funding rounds. BBV has a diverse portfolio, investing in sectors such as B2B SaaS, eCommerce, Fintech, Foodtech, and Healthcare. Some of their notable investments include Hungryroot, Brigit, and Yuvo Health. These companies have seen significant growth and success, reflecting BBV's ability to identify and nurture promising startups. The firm is known for fostering a strong community among founders and professionals, providing extensive support and guidance to early-stage startups. They typically invest around $350,000, focusing on companies with well-researched ideas, working prototypes, or early traction with users or revenue. As of May 2023, BBV announced that it would no longer be making new investments. Despite this, the firm continues to support its existing portfolio companies, helping them navigate growth and sustainability challenges. For startups seeking engagement, BBV's legacy emphasizes the importance of strong preparation and clear demonstration of potential.

Btomorrow Ventures (BTV) is the corporate venture capital arm of British American Tobacco, established in 2020 and headquartered in London. BTV focuses on building transformative and innovative businesses across sectors such as consumer brands, digital transformation, new technologies, and future sciences, with a strong emphasis on Environmental, Social, and Governance (ESG) criteria. BTV has made notable investments in startups like FlexSea, a UK-based company pioneering sustainable, seaweed-derived bioplastics, and Open Book Extracts, a cannabinoid innovation house in North Carolina. Their portfolio includes diverse companies such as Awake Chocolate in Canada, offering functional caffeinated chocolates, and Hesperos in Florida, known for their Human-on-a-Chip® technology​. The firm typically participates in early to growth-stage funding, with an average check size of $1 million. BTV is known for leading investment rounds and has a keen interest in companies that align with their sustainability and innovation goals. They actively collaborate with their portfolio companies through initiatives like Btomorrow Labs, providing strategic support and global distribution channels. Led by Managing Director Juan Palacios, the BTV team operates primarily from London, offering a blend of financial investment and strategic partnerships to accelerate the growth of ambitious founders and their disruptive technologies.

Buckley Ventures, founded in 2020 by Joshua Buckley and based in San Francisco, focuses on early-stage venture capital investments. The firm has made 35 investments across various sectors including hardware, software, and fintech. Notable investments include Rain AI, a company in the hardware industry; Framework, which specializes in consumer electronics; and Symbolica AI, a firm developing artificial intelligence solutions. Buckley Ventures has also invested in NexHealth, a healthcare software company, and Porter Finance, a trading platform. The firm has seen successful exits from companies like Whereby and ScienceIO. The team, led by Joshua Buckley and supported by Jonathan Choi and Paul Barnes, emphasizes supporting innovative startups with strong growth potential. Buckley Ventures aims to back companies that are poised to make significant impacts in their respective fields, leveraging their expertise and network to help these startups scale effectively.

Bullish, headquartered in New York City, is an early-stage venture capital firm that focuses on disruptive consumer businesses. Established in 2015, Bullish invests primarily in pre-seed to Series A rounds, with investments ranging from $500,000 to $3 million. The firm has a strong emphasis on leveraging cultural insights and innovative strategies to support its portfolio companies. Bullish's portfolio includes a range of successful and innovative companies. Notable investments include Captain Experiences, a platform for booking guided outdoor adventures; CUUP, a direct-to-consumer lingerie brand; Function of Beauty, which offers customizable hair, skin, and body care products; and FixMyCar, a mobile auto repair service. Other significant investments include Hello Cake, a wellness brand, and Dirty Labs, a company focused on eco-friendly cleaning products. The firm prides itself on providing more than just capital. They offer strategic marketing, branding, and operational support to help their portfolio companies scale effectively. The team at Bullish includes experienced marketers, strategists, and creatives who work closely with founders to navigate the challenges of growing a business.

Bullnet Capital is a venture capital firm based in Madrid, Spain, specializing in high-technology startups. Founded in 2001 by Javier Ulecia and Miguel del Cañizo, Bullnet Capital focuses on companies with proprietary, breakthrough technologies resulting from significant scientific or technical efforts. They seek startups that have sustainable competitive advantages and can stand the test of time. The firm primarily invests in sectors such as computer hardware, semiconductors, software, and healthcare devices. Their investment strategy emphasizes a hands-on approach, where they not only provide financial support but also strategic and managerial assistance to help companies navigate through their growth phases. Bullnet typically invests between €500,000 and €2,000,000 in early-stage startups. Notable portfolio companies include Digital Legends, Anafocus, and Oncovision, which have benefited from Bullnet's extensive support in both financial and strategic dimensions. The team is led by experienced professionals such as Javier Ulecia, who has a background in aeronautical engineering and an MBA from HEC Paris, and Miguel del Cañizo, a telecom engineer with advanced studies in nanotechnology and photonics. Bullnet Capital's approach focuses on fostering deep, long-term relationships with its portfolio companies, ensuring they have the necessary resources and guidance to succeed in competitive and rapidly evolving markets.

Bullpen Capital, established in 2010, is a venture capital firm based in San Francisco that specializes in post-seed investments. Their focus is on startups that have found product-market fit but are often overlooked by traditional venture capital due to various factors such as market size or early-stage revenue metrics. Bullpen Capital has funded over 100 companies, leveraging their expertise to help these businesses achieve significant milestones within a short period. Notable investments by Bullpen Capital include companies like FanDuel, Grove Collaborative, and Life360, all of which have achieved notable exits. Other significant portfolio companies include IPSY, Braze, and Carbon Health, reflecting their diverse investment strategy across consumer products, enterprise software, health tech, and more. The team at Bullpen Capital includes experienced professionals like co-founder Paul Martino and partners Eric Wiesen and Richard Melmon. Their combined experience spans across various industries and operational roles, providing portfolio companies with robust support and strategic guidance. Bullpen Capital continues to focus on sectors such as e-commerce, health, and enterprise applications, ensuring their portfolio companies receive the necessary resources and mentorship to scale effectively.

Business Finland is a public organization under the Finnish government that aims to support innovation, economic growth, and sustainable development in Finland. Established in 2018 from a merger between Tekes (the Finnish Funding Agency for Innovation) and Finpro (an export and investment promotion agency), Business Finland offers various services including innovation funding, internationalization support, and investment promotion. Its mission is to accelerate the global success of Finnish companies while positioning Finland as a competitive and attractive destination for foreign investments. Business Finland plays a significant role in promoting Finnish industries globally, particularly focusing on sectors like ICT, cleantech, bioeconomy, health, and digitalization. The organization is also deeply committed to sustainability, which is central to its strategy through 2025. It works to foster collaboration between research institutions, businesses, and international stakeholders, driving systemic change in addressing global challenges like climate change. Additionally, Invest in Finland, a key branch of Business Finland, actively attracts foreign direct investment, helping foreign companies explore opportunities in Finland. This initiative strengthens local ecosystems, creating thousands of jobs annually, particularly in high-growth sectors. With over 760 specialists spread across 40 international locations and 16 offices in Finland, Business Finland remains a cornerstone in fostering innovation and economic development within Finland's vibrant tech ecosystem.

Butterfly Ventures, established in 2012, is a leading seed-stage venture capital firm based in Helsinki, Finland, with additional offices in Oulu, Stockholm, Tallinn, and Copenhagen. The firm focuses on deep tech and hardware startups in the Nordics and Baltics. Their investment portfolio includes companies such as Wolt and Supercell, showcasing their commitment to backing transformative technology companies. Butterfly Ventures typically invests in pre-seed, seed, and early-stage rounds, with check sizes ranging from €100,000 to €2 million. They emphasize sustainable and science-based innovations, aligning with the EU's Article 8 and Sustainable Finance Disclosure Regulation (SFDR). Their latest fund, Butterfly Venture Fund IV, raised an initial €47 million, aiming for a total of €100 million to support groundbreaking startups across the region. The team at Butterfly Ventures includes experienced professionals like Juho Risku, co-founder and partner, who has a strong background in digital technologies and entrepreneurship. Other key members include Ville Heikkinen, known for his expertise in VC financing and M&A, and Tanya Horowitz, who brings a wealth of experience from her background in asset management and M&A investment banking in New York. Butterfly Ventures is deeply integrated into the Nordic startup ecosystem, actively seeking companies that have the potential for significant societal, environmental, and economic impact. Startups looking to partner with Butterfly Ventures should focus on innovative solutions that address major global challenges, particularly in deep tech and hardware sectors.

Byers Capital, managed by Blake Byers, is a San Francisco-based family office that focuses on early-stage investments in technology and biotech sectors. Founded in 2021, the firm has quickly established a diverse portfolio, including investments in high-profile companies like Neuralink, NewLimit, and Benchling. Byers Capital is known for its strategic investments in Series A and B rounds, particularly in the healthcare and enterprise applications sectors. The firm primarily invests in the United States but has also made select international investments, such as in the Netherlands. Byers Capital leverages Blake Byers' extensive experience as a former partner at Google Ventures, where he was involved in several successful exits, including companies like Robinhood and Grail. This deep expertise in both venture capital and scientific research allows Byers Capital to support its portfolio companies with not just capital, but also strategic guidance and industry connections​.

ByFounders, established in 2017, is a venture capital firm focused on early-stage investments in the Nordic and Baltic regions. The firm, based in Copenhagen and Stockholm, is known for its collective approach, leveraging a network of successful founders and operators to support its portfolio companies. ByFounders targets pre-seed and seed stage startups, particularly those in industries such as fintech, insurtech, AI, and SaaS. Notable investments include companies like SafetyWing, a global social safety net provider; Uizard, which uses machine learning to turn sketches into digital prototypes; and Normative, which provides carbon accounting software. The firm's investment strategy is deeply rooted in its community, known as the byFounders Collective, which consists of over 40 experienced Nordic and Baltic founders and operators. This collective offers portfolio companies operational expertise and a global network, helping them scale internationally. For example, companies like Corti, an AI health tech startup, and Monta, an EV charging management platform, have benefited from this extensive support network. ByFounders has made significant strides in promoting diversity within its investments. Over half of its portfolio companies have diverse founding teams, aligning with their commitment to fostering inclusive growth in the startup ecosystem.

C2 Ventures is an early-stage venture capital firm established in 2014 by Chris Cunningham and Matt Olivo. The firm focuses on investing in companies developing enterprise software and robotics solutions for legacy industries. Their goal is to provide these companies with the necessary capital and strategic support to improve productivity, capital efficiency, and profit margins. Additionally, C2 Ventures has a strong interest in clean-tech and sustainability solutions. C2 Ventures has raised several funds, including C2V Capital Partners I and II, and the Tributary Fund, which targets pre-seed investments. They provide a hands-on approach, assisting portfolio companies with revenue growth, market traction, cash management, and strategic pivots or exits. The firm emphasizes building strong relationships with founders and leveraging the expertise of their extensive network of successful entrepreneurs and tech executives. Their portfolio includes a diverse range of companies such as Paladin, Driver Technologies, OmniX Labs, and Argyle. The team at C2 Ventures brings extensive experience in asset management, startup growth, and operational expertise, ensuring their portfolio companies receive comprehensive support to achieve success.

C4 Ventures is a distinguished European venture capital firm established in 2012 by Pascal Cagni, a former Apple executive, with offices in Paris and London. The firm specializes in early to mid-stage investments in technology-driven startups, particularly those targeting expansion into European markets. C4 Ventures’ impressive portfolio includes notable investments in companies such as Graphcore, Riskified, and Foursquare. They are recognized for their strategic support and capital, which have been pivotal in helping businesses like Anki and Clippings scale successfully. The firm focuses on sectors including consumer hardware, digital media, and e-commerce, with recent investments in innovative companies like VoltR and Refurbed. C4 Ventures typically leads funding rounds and offers hands-on assistance to their portfolio companies, leveraging the extensive industry experience of their team, including co-founder Boris Bakech and partner Michel Sassano. For startups aiming to engage with C4 Ventures, it's essential to demonstrate a clear path to market leadership and scalability. The firm values innovative approaches and strong market potential, evidenced by their active investment and exit strategies, including significant exits like Riskified and Trouva.

Caffeinated Capital is an early-stage venture capital firm founded in 2013 by Raymond Tonsing and based in San Francisco, California. The firm focuses on investing in transformative technology companies from inception and supporting them throughout their growth stages. Caffeinated Capital has a diversified portfolio across sectors such as consumer, healthcare, fintech, defense, and cryptocurrency. Notable investments include companies like Affirm, Pluto, and Gigster, with exits such as Zoox (acquired by Amazon) and CTRL-Labs (acquired by Meta). The firm has a strong track record of backing successful startups that later attract significant follow-on funding from other major investors. Caffeinated Capital typically invests in pre-seed, seed, and Series A rounds, with an average check size ranging from $2 million to $12 million. The firm is highly selective, often partnering with founders who demonstrate a unique vision and the resilience to bring transformative ideas to fruition. The team at Caffeinated Capital, led by Raymond Tonsing, is known for its hands-on approach, providing strategic guidance, mentorship, and leveraging its extensive network to support portfolio companies. The firm has a global investment outlook but maintains a strong presence in major US tech hubs, particularly San Francisco.

Caixa Capital Risc, established in 2004 and based in Barcelona, Spain, is the venture capital arm of CriteriaCaixa. The firm focuses on investing in innovative companies at their initial and growth stages, particularly in Spain and Portugal. Caixa Capital Risc specializes in three main areas: Information Technology, Life Sciences, and Industrial Technologies. The firm typically invests in rounds ranging from pre-seed to Series B, with investment amounts varying from $500,000 to $5 million. Notable sectors they invest in include analytics, AI, cloud infrastructure, developer tools, edtech, fintech, healthcare services, and robotics. Their extensive portfolio includes companies like Build38, MedLumics, and Recognai, showcasing their diverse investment interests. Caixa Capital Risc is committed to supporting its portfolio companies not only financially but also through strategic guidance and leveraging its extensive network. They have a history of successful exits and are considered a key player in the Spanish and Portuguese startup ecosystems.

Cake Ventures, founded by Monique Woodard, is a venture capital firm that focuses on investing in early-stage companies poised to capitalize on significant demographic shifts. Woodard's investment strategy is built around three key areas: aging and longevity, the increasing spending power of women, and the rise of a new majority as people of color become the fastest-growing consumer groups in the U.S. With a $17 million fund, Cake Ventures primarily invests in pre-seed and seed-stage companies, typically writing checks between $200K and $750K. The firm is committed to supporting startups that address the needs of tomorrow's internet users, particularly those influenced by demographic changes. This includes companies like Mama Foods, a grocery delivery service for the U.S. Latino community, and Guaranteed, a company reimagining hospice care. Woodard's approach is unique in the venture capital landscape, as she emphasizes not just the business potential but also the social impact of these demographic trends. Her firm has backed 12 companies so far, with a significant portion led by women.

Calculus Capital, founded in 1999 by John Glencross and Susan McDonald, is a UK-based venture capital firm focusing on Enterprise Investment Schemes (EIS) and Venture Capital Trusts (VCT). The firm invests in early-stage companies in high-growth sectors such as technology, healthcare, and entertainment. The Calculus VCT offers a diversified portfolio of 30-40 UK companies, providing development and scale-up capital. Investors benefit from tax-efficient opportunities, including 30% income tax relief and tax-free capital gains and dividends if shares are held for at least five years. The Calculus EIS Fund targets Knowledge Intensive Companies, offering similar tax benefits and aiming for a return of £2 for every £1 invested. Calculus Capital is known for its strategic, hands-on approach, supporting companies with strong business models and significant growth potential. The firm's experienced team from leading financial institutions ensures robust support and guidance, contributing to successful exits like those to Microsoft and SAP.

Calm/Storm Ventures, based in Vienna, Austria, is a boutique venture capital firm and exclusive founder network that focuses on early-stage investments in digital health and wellbeing startups. The firm is known for its emphasis on purpose-driven founders who aim to improve life, health, and wellbeing. Calm/Storm Ventures has a distinctive track record of investing in projects that address sensitive and often overlooked areas such as infertility, sexual wellness, mental health, and chronic conditions. Founded in 2020, Calm/Storm Ventures targets super-early stage companies, including pre-seed, seed, and (pre-)Series A rounds. The firm has built a diverse portfolio with investments in companies like Biloba, an instant messaging app for pediatric consultations; Healee, a digital health platform for telehealth services; and Thymia, which aims to make mental health objectively measurable. The investment team at Calm/Storm is composed of founders and entrepreneurs who bring extensive experience and a hands-on approach to supporting portfolio companies. The team includes Lucanus Polagnoli as Founding Partner and CEO, Philippa Allen as Junior Investment Manager, and Johannes Blaschke as Principal. The firm also boasts a high level of diversity, with 50% of its portfolio companies having diverse teams, and 60% of its board members being female. Calm/Storm Ventures is not only a capital provider but also offers deep expertise in business development, market positioning, and global connectivity, helping startups navigate the complexities of the healthcare and wellbeing sectors.

Cambridge Angels, established in 2001, is a prominent UK business angel network based in Cambridge. The group comprises over 60 affluent investors who provide smart capital and mentorship to startups and scale-ups primarily in the UK, focusing on science, engineering, and healthcare technology sectors. They have invested over £150 million in more than 120 companies. Notable investments by Cambridge Angels include companies like Paragraf, Arecor, Eagle Genomics, Privitar, and Healx. The group supports these companies not just financially, with typical investments ranging from £150,000 to £1.5 million, but also through strategic guidance, leveraging their extensive experience as successful entrepreneurs. Cambridge Angels is known for their commitment to fostering innovation without charging founders to pitch, ensuring that the entrepreneurial focus remains on development and growth. This investor group also holds educational sessions for portfolio companies, covering critical topics such as exit strategies and leadership development.

Cambridge Innovation Capital (CIC) is a venture capital firm based in Cambridge, UK, specializing in investing in deeptech and life sciences startups. Established to leverage the rich innovation ecosystem around the University of Cambridge, CIC manages over £500 million across its funds, focusing on supporting early to growth-stage companies. The firm plays a strategic role in fostering innovation by backing ventures that emerge from the Cambridge cluster, including university spinouts and collaborations with research institutes like the Wellcome Sanger Institute. CIC's investment portfolio reflects its emphasis on groundbreaking technology, with companies like CMR Surgical, known for its Versius robotic surgery system, and PragmatIC Semiconductor, which focuses on flexible electronics. The firm also invests in biotech firms like Microbiotica, which leverages the microbiome for therapeutic purposes, and quantum computing ventures such as Riverlane. With its commitment to sustainability and a robust focus on ESG (Environmental, Social, and Governance), CIC aims to create long-term value while fostering responsible business practices. The firm not only provides capital but also strategic support, often co-investing alongside other prominent funds and facilitating connections through initiatives like DeepTech Labs and Start Codon, two accelerators designed to help startups navigate early commercial challenges. Led by Managing Partner Andrew Williamson, CIC remains deeply integrated within the Cambridge ecosystem, collaborating with universities, research hubs, and industry leaders to drive the next wave of technological breakthroughs​.

Camford Capital is a Palo Alto-based venture capital firm that focuses on investing in transformative technologies across sectors like enterprise software, consumer products, fintech, and healthcare. Founded in 2021, the firm partners with early-stage and growth-stage companies in the U.S. and Asia, seeking to back innovative solutions that have the potential to reshape industries globally. Camford has built a strong portfolio that includes notable investments such as CG Oncology and Totus Medicines, which highlight its emphasis on life sciences. Additionally, the firm has backed Viz.ai an AI-driven healthcare company, and Stori, a fintech unicorn offering credit card solutions in Latin America. The firm is particularly known for its ability to identify and support companies that leverage exponential technologies to tackle complex problems in healthcare and financial services. The leadership team at Camford consists of experienced entrepreneurs and investors, including Andrew Gu and Ali Farahanchi, who bring deep operational and investment expertise. Their strategy combines hands-on partnership with founders and an ability to co-invest with global players like General Catalyst and Khosla Ventures. Camford Capital tends to invest anywhere between $500,000 and $10 million, with a preference for leading funding rounds. Entrepreneurs seeking investment can reach out to the firm through its website for inquiries.

Canaan is a leading early-stage venture capital firm that focuses on transformative ideas in the technology and healthcare sectors. With a strong history spanning over 35 years, Canaan has invested in notable companies such as Instacart, LendingClub, The RealReal, and Match.com. The firm has managed to achieve impressive exits, including IPOs for companies like TheRealReal, Arvinas, and Day One Biopharmaceuticals. Canaan’s investment strategy covers a wide range of industries including enterprise software, consumer tech, fintech, and frontier tech. They are particularly noted for their deep involvement in healthcare, with significant investments in areas such as oncology, immunology, and neurology. Their portfolio includes companies like Dexcom, Synthekine, and Vivace Therapeutics, among others. The firm manages over $6.8 billion in assets and recently closed its thirteenth fund with $850 million to continue supporting innovative startups through their early and growth stages. This new capital will help expand their investments in robotics, AI/ML, cybersecurity, and genetically defined precision medicines​.

Canapi Ventures is a venture capital firm focused on early to growth-stage fintech companies. With the recent launch of its $750 million Fund II, Canapi has increased its total assets under management to over $1.4 billion. The firm is backed by nearly 70 financial institutions and strategic investors, known as the Canapi Alliance, which provides a unique network to support portfolio companies. Canapi's investment strategy is centered on financial technology and related sectors, including fraud and identity, financial infrastructure, lending and credit, payments, and real estate technology. They have expanded their scope to include areas like AI, cybersecurity, and climate tech with investments in companies such as DynamoFL, Island, and Crux Climate. Notable investments from Canapi's Fund I include Alloy, Built, Thoropass, and Greenlight, with successful partnerships generating significant annualized revenue and job creation. The firm typically invests between $10 million and $50 million in emerging companies and has a strong track record of leading multiple funding rounds for its portfolio companies​. Canapi Ventures is headquartered in Wilmington, NC, with additional offices in Washington, D.C., New York, and San Francisco. The team is led by experienced financial services professionals, including Managing Partners Gene Ludwig and Chip Mahan, who leverage their extensive industry connections and regulatory expertise to help portfolio companies navigate complex challenges and maximize their impact.

Cantos Ventures, established in 2016 and headquartered in San Francisco, focuses on pre-seed and seed-stage investments in frontier technologies. The firm invests in sectors such as climate tech, computational biology, aerospace, and advanced computing. Notable companies in their portfolio include Solugen, Astranis, and Public, reflecting their commitment to transformative technologies. Cantos Ventures emphasizes investing in high-potential startups tackling significant global challenges. Recent investments include Furno Materials, which raised $6.5 million for decarbonizing cement production, and Shinkei Systems, which secured $6.27 million to innovate in sustainable fish processing. The firm collaborates with co-investors like Y Combinator and 8VC, ensuring a robust support network for their portfolio companies. The team at Cantos Ventures, led by Ian Rountree and Natalie Estrella, leverages extensive experience to support founders. They adopt a hands-on approach, providing strategic guidance and access to global networks. Startups seeking investment should demonstrate strong technical capabilities and a clear vision for addressing large-scale problems. Cantos Ventures is recognized for its selective and impactful investment strategy, often leading rounds with substantial financial commitments to drive growth and innovation

Canvas Ventures is a Portola Valley-based venture capital firm founded in 2013 by Rebecca Lynn, Gary Little, and Paul Hsiao. Specializing in Series A and B investments, Canvas Ventures primarily focuses on fintech, digital health, AI, marketplaces, and logistics sectors. With a strategic emphasis on companies poised for significant growth, the firm offers more than just capital, providing extensive go-to-market expertise, sales strategy, and growth guidance to their portfolio companies. Notable investments include Luminar Technologies, which went public via SPAC in 2020, and successful ventures like Zola, Vida Health, and Transfix. Their recent fund, CV3, raised $350 million, bringing their total capital raised to $835 million. Canvas typically leads funding rounds with investments ranging from $5 million to $15 million. The firm is led by experienced partners, including Rebecca Lynn, a renowned investor with deep expertise in consumer credit and healthtech. Canvas Ventures has a mission-driven approach, deeply engaging with their portfolio companies to ensure their success. The team has also established the Canvas GTM Council, comprising top marketing and sales professionals who provide invaluable insights to portfolio companies. Canvas Ventures prefers to work with founders who are tackling transformative problems and are prepared for the long-term journey of building significant companies. They maintain a collaborative and supportive relationship with entrepreneurs, helping them navigate challenges and scale their businesses effectively.

Capagro is a Paris-based venture capital firm established in 2014, focusing on investments in the AgTech and FoodTech sectors. The firm aims to accelerate innovation and development across the agricultural and food value chains, supporting companies that offer sustainable and impactful solutions. Capagro's portfolio includes notable companies such as Naïo Technologies, which develops agricultural robotics, Cuure, a personalized health and wellness provider, and NICK'S, a snack food manufacturer. Other significant investments are in La Belle Vie, an e-commerce grocery platform, and ecoRobotix, which specializes in precision farming robotics. The firm typically invests between €1 million and €5 million per round, emphasizing early-growth companies that already have significant revenues or are close to commercialization. Capagro has made 36 investments to date, with a strategy focusing on three main segments: upstream agricultural production, downstream consumer food products, and energy efficiency innovations in the agro-industrial sector. Capagro is led by Jean-Baptiste Cuisinier and Jérôme Samson, who bring extensive experience in food, agribusiness, and venture capital. Their deep industry knowledge and strategic support have made Capagro a valuable partner for innovative startups aiming to scale and make a global impact. The firm manages assets of approximately €124 million, backed by notable investors including Bpifrance and Groupe Avril. Capagro continues to seek new investment opportunities to bridge the funding gap in the European AgTech and FoodTech industries.

Capital Factory is a prominent venture capital firm and accelerator based in Austin, Texas, that serves as a major hub for entrepreneurs across Texas. Founded in 2009, it supports early-stage tech startups through investments, mentorship, and community access. Its program emphasizes long-term engagement, providing startups with free coworking space, extensive mentorship from industry leaders, and introductions to investors. Capital Factory stands out with its robust network, which includes hundreds of mentors and partnerships with major tech companies like Amazon and Google, offering hosting credits and other resources to its portfolio companies. Capital Factory’s accelerator is not your typical boot camp. Instead, startups can immerse themselves in the program, gaining the support needed to scale, with Capital Factory taking a 1% equity stake. The firm is particularly active in sectors like artificial intelligence, digital health, education technology, and SaaS, making investments in companies such as Zen Business and Aceable. Beyond its Austin headquarters, Capital Factory has expanded its influence with programs in Dallas, Houston, and San Antonio, making it a central player in the Texas startup ecosystem.

Capricorn Partners, headquartered in Leuven, Belgium, is a leading independent manager of venture capital, growth capital, and quoted equity funds. The firm focuses on innovative companies that leverage technology as a competitive advantage, particularly in sectors such as digital technologies, health, and cleantech. Capricorn Partners manages several funds, including the Capricorn Cleantech Fund, Capricorn Digital Growth Fund, Capricorn Health-Tech Fund, and Capricorn Fusion Fund, which targets opportunities with a specific China strategy. They also manage Quest for Growth, integrating both quoted and private investments, focusing on European companies expected to produce higher than average growth in digital, health, and clean technologies. The firm has a strong commitment to ESG principles and aims to create both financial return and strategic value for its clients. Their investment philosophy is rooted in supporting innovative sectors that drive positive change, making them a pivotal player in the venture capital landscape. Capricorn’s team comprises experienced investment managers with deep technology expertise and broad industrial experience. They offer a unique mix of technology and investment expertise, creating an ecosystem that supports superior returns through the combination of investable capital, innovative ideas, capable entrepreneurship, and business management. For entrepreneurs, Capricorn Partners provides not only capital but also strategic guidance and support, leveraging their extensive network and industry knowledge to foster growth and innovation in their portfolio companies​.

Carbon Silicon Ventures, founded in 2022 and based in New York City, is a venture capital firm that invests in early-stage companies at the cutting edge of biotechnology and healthcare. With a focus on pre-seed, seed, and Series A rounds, the firm aims to back startups applying engineering and scalable technologies to revolutionize life sciences. The firm's primary sectors include lab automation, drug development, and biotech SaaS, targeting companies that use innovative methods to disrupt the healthcare landscape. Led by Nish Bhat, co-founder of Color, Carbon Silicon Ventures is deeply embedded in the biotech community, leveraging Bhat's experience in healthcare and technology to identify promising startups. The firm has already made significant investments in companies like Ansa Biotechnologies, known for its breakthroughs in synthetic biology, and Octant Bio, a leader in drug discovery​. Carbon Silicon Ventures typically writes checks ranging from $100K to $500K and focuses on U.S.-based companies. It positions itself as a high-conviction investor, supporting founders that aim to scale transformative solutions. The firm has a growing portfolio that includes promising biotech startups, aligning itself with major co-investors like Sequoia and Andreessen Horowitz. With a clear mission to apply engineering principles to healthcare, Carbon Silicon Ventures is well-positioned to make a lasting impact on the future of medicine.

Carbon13 is a venture builder focused on addressing the climate emergency by helping founders create scalable startups that contribute significantly to reducing carbon emissions. Based in Cambridge and Berlin, Carbon13’s programs support entrepreneurs from the earliest stages of ideation through to pre-seed investment. Their goal is for each venture to eventually reduce 10 million tonnes of CO2e annually once scaled. The organization has launched over 70 climatetech ventures since 2021, including notable startups like Kita, which offers the world’s first carbon removal insurance, and Materials Nexus, which uses AI and quantum mechanics to design low-carbon materials​. Carbon13's venture builder program focuses on both technical and commercial founders, fostering collaborations between scientists, engineers, and entrepreneurs to build impactful solutions. Participants gain access to a vast network of domain experts and investors, including partnerships with organizations like Barclays and EY. The program emphasizes a dual focus on achieving commercial success and measurable carbon reduction. The fund actively invests through its SEIS Funds, targeting ventures that align with its mission of achieving net-zero emissions by 2050.

Carduso Capital is a Groningen-based venture capital firm focused on supporting innovative technology companies, particularly those linked to the University of Groningen and the University Medical Center Groningen. The fund targets sectors such as life sciences, energy, and sustainability, with a special interest in spin-offs and startups leveraging university research. Carduso Capital’s investments range from €100,000 to €5 million, covering companies at various stages of growth, from seed to expansion phases. In addition to financial backing, Carduso takes an active role in providing strategic and managerial support to its portfolio companies, ensuring they have the resources and guidance needed to thrive. Their investment strategy emphasizes long-term collaboration and supports multiple financing rounds if necessary. The fund looks for businesses with completed proof-of-concept and functional prototypes that are nearing market readiness. Portfolio companies must address unmet needs with clear, realistic market-entry strategies. Some notable investments include Ivy Medical, Qdi Systems, and ViroTact, reflecting their focus on high-potential technologies within their core sectors. Led by fund managers Koos Koops, Robert Polano, and Frits Kok, Carduso Capital combines deep industry knowledge with a strong network, enabling startups to benefit from both financial and operational expertise. The team prioritizes fostering long-term success, even during challenging periods, and is deeply involved in ensuring the sustainable growth of its companies. Their active engagement and sector-specific focus make them a valuable partner for tech-driven startups seeking strategic and financial support.

Casdin Capital, established in 2012 by Eli Casdin, is a New York-based venture capital firm with a focus on life sciences and healthcare. The firm specializes in investing in companies that are at the forefront of scientific and technological advancements in areas such as molecular medicine, biotechnology, genomics, and synthetic biology. Notable investments by Casdin Capital include high-impact companies like 23andMe, Adaptive Biotechnologies, Recursion Pharmaceuticals, and Ginkgo Bioworks. These investments highlight the firm’s commitment to transformative technologies in health care, gene editing, and diagnostic platforms. Casdin Capital's strategy revolves around funding companies that leverage data and precision-based therapies to revolutionize the healthcare industry. They focus on early-stage to late-stage investments, providing substantial financial support to help these companies scale and achieve significant milestones. The firm has managed to build a robust portfolio with 250 investments and 87 exits, demonstrating a strong track record of successful investments and strategic exits. Key team members include Eli Casdin as the Founder and Chief Investment Officer, Alexandria Fisk as Chief Operating Officer, and Lawrence Canzoneri as Chief Financial Officer. The team’s expertise and deep industry knowledge enable them to identify and support innovative startups effectively. Casdin Capital's approach combines strategic investments with deep sector expertise, positioning them as a leading player in the life sciences investment landscape, actively supporting companies that are poised to make groundbreaking advancements in health and biotechnology.

AVG Funds, also known as Alumni Ventures Group, is a prominent venture capital firm that leverages the power of alumni networks to invest in innovative startups across various sectors. Founded with the mission to democratize venture capital, AVG Funds has become one of the most active venture firms globally. They manage over $200 million in assets and have made more than 115 investments in the past year alone. AVG Funds focuses on diverse industries, including AI and machine learning, health tech, fintech, cleantech, and cybersecurity. Notable investments include companies like Adventr, a media and information services platform, and Eclypsium, which specializes in cybersecurity for enterprise hardware. Their portfolio also features startups like PartySlate, a digital platform for event planning, and Venus Aerospace, a company developing high-speed transport technologies. The firm operates through a network of alumni funds associated with top universities such as Harvard, MIT, Stanford, and Yale. This structure enables AVG to tap into a vast network of alumni entrepreneurs and investors, providing a rich source of deal flow and support for portfolio companies. AVG Funds typically invests in early to growth-stage companies, with check sizes ranging from $100,000 to $2 million. They emphasize a hands-on approach, providing not only capital but also strategic guidance and connections to help startups scale and succeed.

Catalio Capital Management is a multi-strategy investment firm focused on breakthrough biomedical technology and innovative healthcare companies. Founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein, Catalio specializes in private equity, private credit, and public equities strategies, supporting companies from inception through to IPO or acquisition. The firm’s portfolio includes notable companies such as Affini-T, which is developing precision T-cell therapeutics for solid tumors, and Boost Neuroscience, focusing on therapies to combat cognitive aging and neurodegeneration. Catalio has also invested in companies like Octant, Inc., and Pheast Therapeutics, demonstrating a strong commitment to advancing precision medicines and novel cancer therapies. Catalio's strategy involves close collaboration with their portfolio companies, leveraging a network of over 36 world-renowned scientists to identify and invest in cutting-edge biomedical technologies. This approach has led to successful investments in companies like Thrive Earlier Detection, which was acquired by EXACT Sciences for $2.15 billion, and Personal Genome Diagnostics, acquired by LabCorp for $500 million.

Catapult Ventures, based in Leicester, UK, is a seasoned venture capital firm with a focus on early-stage and growth investments. They manage several distinct funds, including the GM&C Life Sciences Fund and the Catapult Growth Fund. Their investments span various sectors such as healthcare, pharmaceuticals, manufacturing, and software. Notable portfolio companies include Accutronics, Lumora, and Oxford Cryosystems​. Catapult Ventures primarily invests in the UK, targeting businesses in the Greater Manchester, Cheshire, and Warrington regions. Their approach involves not just funding but also active involvement in the strategic direction, senior hiring, and financial planning of their portfolio companies. Founded by experienced investors, Catapult Ventures is committed to creating long-term value through strategic partnerships with ambitious entrepreneurs. They prefer to be approached through detailed business proposals that clearly outline the innovative aspects and market potential of the startup. Key team members include Laurence Vaughan and Nick Wright, who bring extensive expertise and a hands-on approach to their investment strategy. This team structure ensures that portfolio companies receive tailored support and guidance to scale successfully.

Cathay Capital is a global investment firm known for its cross-border investment strategies, supporting companies across various stages from venture to growth. Founded in 2007, the firm has established a strong global presence with offices in major cities such as Paris, New York, Shanghai, and San Francisco. With over $4.5 billion in assets under management, Cathay Capital invests across sectors including healthcare, consumer goods, digital technology, and energy, aiming to foster sustainable transformation and globalization. The firm operates through several specialized funds, such as Cathay Innovation, Cathay Health, and regional initiatives like the Seaya Cathay Latam Fund. Cathay Innovation focuses on digital transformation, investing in companies at the forefront of the tech revolution, with a portfolio that includes firms like Chime, KaiOS, and Ledger. Meanwhile, Cathay Health, a €500 million fund, targets companies at the convergence of healthcare, life sciences, and technology, helping ventures scale globally with investments in firms like Tissium and Kojin Therapeutics. Cathay Capital's strategy emphasizes connecting startups with established corporations to drive innovation and expansion, leveraging its extensive network across Europe, North America, and Asia. The firm has also launched partnerships to enhance its reach, such as the collaboration with Seaya Ventures to support Latin American startups, reflecting its commitment to fostering diverse and sustainable growth globally.

Cathay Innovation, founded in 2015, is a global venture capital firm affiliated with Cathay Capital. The firm focuses on multi-stage investments in innovative startups across various sectors, including AI, fintech, digital health, consumer tech, and energy. With a presence in North America, Europe, Asia, and Latin America, Cathay Innovation leverages its global network to support entrepreneurs in scaling their businesses. Notable investments in Cathay Innovation's portfolio include Ledger, a leading provider of blockchain-based hardware wallets for cryptocurrency, and Glovo, a Spanish on-demand delivery service that was acquired by Delivery Hero. Other significant investments are Owkin, which uses AI for drug discovery and precision medicine, and Kredivo, a fintech company providing consumer loans in Indonesia. The firm has also seen several successful exits, such as the IPO of Wallbox, a smart charging company listed on the New York Stock Exchange, and the acquisition of Getaround, a peer-to-peer car sharing service. Cathay Innovation has a strong track record of identifying and nurturing high-growth companies, with multiple portfolio companies achieving unicorn status. Led by a diverse team of 45 members, including 17 partners, Cathay Innovation emphasizes a collaborative approach, providing strategic support and leveraging its extensive ecosystem to help startups thrive globally. The firm continues to drive innovation and positive impact through its investments in technology-driven companies.

Cathexis Ventures is a venture capital firm based in Houston, Texas, and serves as the venture arm of Cathexis Holdings. Established in 2018, Cathexis Ventures has a diverse investment portfolio with over 100 companies. They primarily focus on seed-stage investments but also participate in pre-seed and Series A rounds. Their investment strategy includes an 80% focus on seed, 10% on pre-seed, and 10% on Series A investments, with initial check sizes ranging from $250,000 to $1,000,000, and up to eight-figure follow-on investments. The firm invests across various sectors, including SaaS (60%), hardware (30%), and consumer (10%) products, with a geographic focus of 70% in North America and 30% internationally. Notable investments include companies like Betterhalf, an AI-enabled matchmaking platform, and BlueCargo, which focuses on smarter container movement. Other significant investments span industries such as healthcare compliance (Verifiable), construction operations (Tenderd), and carbon capture technology (Heimdal). Cathexis Ventures is led by a team of experienced investors and professionals who aim to support extraordinary founders building innovative products with speed and efficiency.

Cavallo Ventures, the venture capital arm of Wilbur-Ellis, strategically invests in innovative startups across biotechnology, agriculture, and food tech industries. Notable investments include companies like Andes, which focuses on sustainable agriculture technology, and Debut Biotech, known for biotherapeutic innovations. The fund primarily targets startups in North America, especially those in California. Cavallo Ventures typically participates in Series A to Series D rounds, often co-investing with other leading funds such as Bessemer Venture Partners and Mayfield. Their investment strategy is centered on supporting technological advancements that can be integrated within Wilbur-Ellis’s existing business operations, providing startups with market access and industry expertise. The fund prefers to invest in startups that align with their focus on sustainability and advanced agricultural technologies. Recent investments highlight Cavallo’s commitment to sustainability and innovation, with companies like Smartwyre and Beta Hatch securing significant funding. The average check size ranges from $5 million to $10 million, and they are known to be active participants in 2-6 investment rounds annually. Key team members include Michael Wilbur and Cavallo’s team of experienced investors based in San Francisco. Startups seeking investment are advised to highlight their innovative approaches and potential for integration into Wilbur-Ellis's ecosystem. Cavallo Ventures values a collaborative approach, often leading investment rounds and providing strategic support to portfolio companies.

CDP Venture Capital is a leading venture capital firm based in Italy, launched with the goal of accelerating the country's innovation ecosystem. It operates as part of the National Innovation Fund (Fondo Nazionale Innovazione), with the primary aim of fostering the growth of startups across various sectors, including deep tech, medtech, biotech, digital, and more. The firm is driven by the mission to shape Italy's future by investing in high-potential businesses that are transforming strategic industries. CDP manages over €1 billion in assets and works to make venture capital a key pillar of Italy's economic development. The firm invests at various stages, from pre-seed and seed funding to Series A and beyond, with typical investments ranging between €1.5 million and €3 million. Their portfolio includes promising startups such as Empatica, GreenBone, and Mindesk, and they collaborate with national agencies and international partners to support Italy's entrepreneurial growth. A key initiative of CDP Venture Capital is its focus on technology transfer, helping bridge the gap between academic research and commercial success. The firm also actively promotes innovation in areas like AI, web 3.0, and cybersecurity, and it plays a critical role in positioning Italy as a hub for high-tech startups.

Cencora Ventures, formerly known as AB Health Ventures, is the corporate venture arm of Cencora (previously AmerisourceBergen). Launched in 2022, the $150 million fund focuses on investing in early-stage healthcare startups that aim to transform the future of healthcare for both humans and animals. By leveraging Cencora's vast experience and resources, Cencora Ventures offers more than just capital; it actively supports startups with commercialization, distribution, and scalability. The fund is deeply integrated with Cencora’s global pharmaceutical supply chain, allowing it to facilitate connections with healthcare providers, pharmacies, and biotech firms. Cencora Ventures' portfolio includes companies such as SteadyMD, a telehealth infrastructure provider, and Trakcel, which offers solutions for cell and gene therapy orchestration. The fund focuses on areas like digital health, patient management, and decentralized clinical trials, aiming to improve healthcare delivery and outcomes across the globe. With a presence in over 50 countries, Cencora Ventures leverages its parent company’s global network to accelerate the growth of its portfolio companies, offering strategic support such as pilot programs, rapid prototyping, and introductions to a broad customer base. This integration helps emerging companies scale their innovations more efficiently while navigating the complex healthcare ecosystem​.

CDTI (Centro para el Desarrollo Tecnológico Industrial) is a Spanish public business entity under the Ministry of Science and Innovation. It supports technological development and innovation within Spain, mainly by channeling financial and technical assistance to companies working on R&D&I projects. One of its key initiatives, Innvierte, is a venture capital program designed to foster investment in innovative, high-tech startups. Through Innvierte, CDTI co-invests with private capital in technology-based enterprises, targeting sectors like biotech, fintech, artificial intelligence, and digital media. The program has committed over €450 million to co-investment projects and venture capital funds, positioning itself as a critical player in Spain’s innovation ecosystem. CDTI has been involved in significant rounds of funding for companies like Atani, Bdeo, and Odilo. CDTI’s investment approach focuses on supporting early-stage companies with disruptive potential, aiming to bridge the gap between innovation and commercialization. This public-private partnership strategy helps drive Spain’s technology transfer and entrepreneurial growth, supporting industries crucial to the country's economic future.

Centre Street Partners, founded in 2015 and based in New York, focuses on early-stage investments in the technology sector. Their investment strategy targets companies that develop frontier technologies for a rapidly evolving world. Notable investments include Drunk Elephant, Briogeo Hair Care, and Parade, all of which have seen successful exits. The firm invests primarily in the information technology sector, with a diverse portfolio that includes companies like OffDeal, Scream Truck, and Arcee.ai. Centre Street Partners typically invests in seed and early-stage rounds, supporting companies with innovative and scalable solutions. The team is led by General Partners Abie Cohen and Jonathan Kerstein, who bring significant expertise and experience to the firm. Centre Street Partners is committed to partnering with ambitious founders and providing the necessary resources to help their portfolio companies grow and succeed.

Cercano Management is a venture capital firm spun out from Vulcan Capital, originally established by Microsoft co-founder Paul Allen. Based in Bellevue, Washington, with a new office in Atlanta, the firm focuses on early-stage investments across sectors like technology, consumer, life sciences, and data intelligence. With a patient and methodical approach, Cercano has over two decades of investment experience, boasting a diverse portfolio of more than 120 companies. The firm is particularly active in both the West Coast and Southeast U.S., with an increasing presence in Atlanta to capitalize on early-stage opportunities in emerging markets. Key investments include Group14 Technologies, AdaptX, and Twelve, demonstrating their strong interest in transformative technologies and sustainability ventures. Cercano’s strategy revolves around long-term partnerships, often leading early rounds but maintaining flexibility to support companies through later stages. Their average check size varies, but they are known to lead or co-lead rounds, particularly in seed and Series A investments. Startups looking to engage with Cercano should prioritize demonstrating innovative solutions and a strong growth trajectory. The team, led by CEO Christopher Orndorff and supported by leaders like Daley Ervin in Atlanta and Tommy Teo in Singapore, offers global insights with a deep expertise in scaling tech companies.

CerraCap Ventures, based in Costa Mesa, California, is a global venture capital firm focused on early-stage B2B technology companies. Their key sectors are health tech, enterprise AI, and cybersecurity. Using their unique Sales & Scale™ model, they guide startups through an industrialized process designed to accelerate sales, scale product development, and facilitate successful exits. CerraCap leverages an extensive network of Fortune 500 CXOs to secure early proofs of concept and streamline product adoption. Their investment strategy is geared toward companies that solve real-world problems in healthcare and digital security, with a focus on chronic disease management and securing digital environments. Some notable portfolio companies include Deep Instinct and Dathena, specializing in cybersecurity through AI-driven solutions. CerraCap often leads rounds and provides hands-on support to help startups achieve growth, reduce sales cycles, and gain traction with key customers. The team, led by co-founders Saurabh Ranjan and Saurabh Suri, draws on years of industry expertise to mentor and position companies for success in global markets​.

Chalmers Ventures, founded in 1997 and headquartered in Gothenburg, Sweden, is a leading venture capital firm focused on deep tech startups. The firm specializes in early-stage investments, primarily targeting sectors like green tech, information technology, communication, new materials, and health tech. Chalmers Ventures has a diverse portfolio of around 100 companies, investing in startups that offer innovative solutions to global challenges. Notable investments include Irisity AB, Minesto, Smoltek AB, and Sinonus. The firm employs an evergreen investment model, reinvesting returns into new ventures to foster continuous innovation and growth. The investment strategy of Chalmers Ventures emphasizes supporting tech-based companies from their initial stages through growth, with funding amounts ranging from SEK 1 million for pre-seed to SEK 25 million for growth capital. They focus on startups with high scalability, strong entrepreneurial teams, and significant sustainability impacts. In 2023, Chalmers Ventures increased its investment pace, allocating SEK 70 million to support companies during turbulent market conditions. This commitment reflects their long-term investment approach and dedication to advancing research-based innovations into viable commercial solutions.

Change Ventures, founded in 2016 and headquartered in Tallinn, Estonia, is a leading venture capital firm focused on early-stage investments in the Baltic region. The firm has built a strong portfolio with notable investments in companies such as Formaloo, a software development applications firm, and RivalSense, a business productivity software company. They emphasize supporting ambitious Baltic founders across various sectors including aerospace, defense, and hospitality. Change Ventures has made 59 investments to date, demonstrating their commitment to nurturing innovative startups. They have seen successful exits, including Nordigen, a company acquired in 2022. The firm's investment strategy is centered around providing not only capital but also mentorship and strategic guidance to help startups scale effectively. The team at Change Ventures includes experienced professionals like Andris Berzins, who has held C-level roles in successful startups and co-founded TechHub Riga and TechChill. Other key members include Yrjö Ojasaar, a seasoned tech-startup CEO and angel investor, and Rait Ojasaar, an experienced tech entrepreneur and mentor. This diverse team brings a wealth of expertise and a deep understanding of the startup ecosystem in the Baltic region. By leveraging their extensive network and deep industry knowledge, Change Ventures continues to play a pivotal role in the growth and success of early-stage startups in the Baltics​.

Checkmate Capital is a venture capital and strategic advisory firm based in Pasadena, California, with a global reach, including a presence in Seoul, South Korea. Founded in 2017, Checkmate Capital focuses on investments in biotechnology, agriculture and waste technology, energy technology, and diversified technologies. The firm is deeply involved in the sectors it invests in, offering both financial backing and strategic advisory services to help companies grow and succeed. Checkmate Capital's portfolio spans a wide range of industries, including high-tech areas like biotechnology, where they invest in companies developing innovative health solutions, and energy technology, focusing on environmentally friendly and efficient energy solutions. The firm prides itself on its disciplined approach to investment, working closely with companies to create synergies that enhance value across its portfolio. In addition to its investment activities, Checkmate Capital also provides commercial and transaction advisory services, facilitating international licensing opportunities and partnerships that help its portfolio companies expand globally.

Cherry Ventures, founded in 2012, is an early-stage venture capital firm based in Berlin, with additional offices in London and Stockholm. The firm primarily invests in pre-seed and seed-stage startups across various sectors, including fintech, climate tech, consumer products, health tech, mobility, and SaaS. Cherry Ventures is led by partners Filip Dames, Christian Meermann, and Sophia Bendz, all of whom have extensive entrepreneurial experience from building companies like Zalando and Spotify. The firm recently launched its fourth fund at €300 million, focusing on disruptive technologies including crypto and web3. Notable portfolio companies include Infarm, AUTO1 Group, FlixBus, TWAICE, and Cazoo.

Cherubic Ventures is a venture capital firm that specializes in early-stage investments, focusing on transformative industries in both the US and Asia. With over $400 million in assets under management, the firm has a portfolio that includes more than 150 startups. Notable investments include Flexport, Hims & Hers, Calm, Ring, Wish, and Paidy, showcasing their ability to identify and support high-growth potential companies. Founded in 2014 by Matt Cheng, Cherubic Ventures operates from key locations in San Francisco, Taipei, and Beijing. Their investment strategy targets seed-stage companies that have the potential to disrupt industries. They typically invest in sectors such as fintech, health tech, consumer internet, and enterprise software, aiming to back ambitious founders from the earliest stages. Cherubic Ventures is known for its hands-on approach, providing more than just capital. They offer strategic guidance and support to help startups scale. Their active involvement in their portfolio companies has led to successful exits, including high-profile acquisitions and IPOs. The firm’s geographic focus allows them to bridge the gap between Western and Asian markets, providing unique opportunities for startups to expand globally. Cherubic Ventures' team is composed of experienced investors and entrepreneurs who leverage their extensive networks to help startups succeed.